T65.843

Clinical Causes: Deliberate administration of xylazine without consent (assault). Use of xylazine surreptitiously as a form of attack or intimidation. Attempted poisoning or harm involving the injection or ingestion of xylazine.

Key Symptoms: Severe sedation or drowsiness. Respiratory depression or difficulty breathing. Low heart rate (bradycardia). Hypotension (low blood pressure). Unresponsiveness or coma. Loss of coordination or muscle weakness. Nausea, vomiting, or abdominal discomfort. Cold or clammy skin. Potential seizures in severe cases.

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and medical testing. Healthcare providers may perform the following: - Review patient history and witness accounts for signs of assault. - Conduct physical examinations focusing on neurological and cardiovascular status. - Laboratory analysis of blood or urine samples to detect xylazine levels. - Imaging studies if necessary to rule out other trauma-related injuries. - Differential diagnosis to exclude other sedatives or toxins. Prompt identification of xylazine toxicity is essential for effective management and to address underlying causes such as assault.

Treatment Protocols: Treatment strategies focus on stabilizing the patient's vital functions and preventing further harm: - Supportive care including oxygen therapy and intravenous fluids. - Monitoring of respiratory and cardiac functions. - Use of medications to reverse severe sedation or to support blood pressure if hypotension occurs. - Activated charcoal may be used if ingestion was recent to limit absorption. - Mechanical ventilation in cases of respiratory depression. - Addressing the psychological and social aspects related to the assault. - Reporting and collaborating with law enforcement if assault is suspected. Healthcare practitioners should be prepared to provide comprehensive care tailored to the severity of toxicity and the patient's specific needs.